SCHEMBL627263

SCHEMBL627263

O=C(Nc1ncns1)C(OC1CCC2(CCCCC2)C1)c1ccc(S(=O)(=O)C2CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.51
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626817 0.76 GCK (0.54) GCKKCNH2
SCHEMBL10140456 0.75 GCK (0.63) GCK
SCHEMBL626479 0.75 GCK (0.54) GCKKCNH2
SCHEMBL10141361 0.74 GCK (0.45) GCK
SCHEMBL10140457 0.71 GCK (0.50) GCK
SCHEMBL2650575 0.69 GCK (0.73) GCK
SCHEMBL2650527 0.69 GCK (0.73) GCK
SCHEMBL9071826 0.69 GCK (0.51) GCKKCNH2
SCHEMBL11972355 0.68 GCK (1.00) GCK
SCHEMBL623031 0.68 GCK (0.65) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO claimed